• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, May 16, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

ESMO World Congress on Gastrointestinal Cancer

Bioengineer by Bioengineer
June 19, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Around 3,500 oncology professionals and researchers from around the world will learn about the latest advances in the field at the 21st ESMO World Congress on Gastrointestinal Cancer

Lugano, Switzerland, 19 June 2019 – Around 3,500 oncology professionals and researchers from around the world will learn about the latest advances in the field at the 21st ESMO World Congress on Gastrointestinal Cancer (1) taking place in Barcelona, Spain, from 3 to 6 July 2019.

The ESMO World GI Congress represents the year’s most important gathering designed to focus on reversing the current global statistics that rank gastrointestinal malignancies as the leading causes of cancer deaths worldwide.

The Scientific Committee, (2) composed of some of the world’s leading experts in gastrointestinal cancers, has worked to develop a robust and clinically relevant scientific programme, (3) which will be enriched by the presentation of latest clinical data.

Abstracts will be published online as a supplement of Annals of Oncology. (4)

Embargo policy

All abstracts will be made available online on Tuesday, 2 July 2019 at 08:00 Central European Summer Time.

Abstracts selected by the Scientific Committee for Oral presentation (designated with an O or LBA or SO before their number) are embargoed until the end of the scientific session during which they are presented.

Further details on the abstracts embargo can be found here. (5)

Media registration

The ESMO World GI Congress welcomes media interested in obtaining information and reporting on cancer issues. Registration is free to bona fide journalists on presentation of a letter of assignment and a valid press card.

Please follow the instructions of the Media registration process. (6) Media registration in advance is strongly recommended.

We look forward to welcoming you in Barcelona!

The International Convention Center of Barcelona

Centre de Convenciones Internacional de Barcelona (CCIB)

Placa de Willy Brandt 11-14
08019 Barcelona, Spain

For further information please contact:

ESMO Press Office

E-mail: [email protected]

###

    1 https://www.esmo.org/Conferences/ESMO-World-GI-2019

    2 https://www.worldgicancer.com/steeringcommittee

    3 https://www.eventscribe.com/2019/WorldGI/agenda.asp?pfp=FullSchedule

    4 https://www.esmo.org/Membership/Member-Benefits/Annals-of-Oncology

    5 https://www.worldgicancer.com/abstracts

    6 https://www.worldgicancer.com/newsroom

About the ESMO World Congress on Gastrointestinal Cancer

The ESMO World Congress on Gastrointestinal Cancer represents the year’s most important gathering designed to focus on reversing the current global statistics that rank gastrointestinal malignancies as the leading causes of cancer deaths worldwide.

Media Contact
ESMO Press Office
[email protected]
http://esmo.org/Press-Office/Press-Releases/ESMO-World-Congress-Gastrointestinal-Cancer-Announcement

Tags: cancerClinical TrialsHealth Care Systems/ServicesHealth ProfessionalsMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Carboplatin ± Nivolumab in Metastatic TNBC Trial

May 16, 2026

Genetic Dosage Influences Parkinson’s Cognitive Decline

May 16, 2026

Loneliness Forecasts Parkinsonism Decline: Long-Term Study

May 16, 2026

New Kitasatospora Species and Synonym Proposed

May 16, 2026
Please login to join discussion

POPULAR NEWS

  • Research Indicates Potential Connection Between Prenatal Medication Exposure and Elevated Autism Risk

    843 shares
    Share 337 Tweet 211
  • New Study Reveals Plants Can Detect the Sound of Rain

    730 shares
    Share 291 Tweet 182
  • Salmonella Haem Blocks Macrophages, Boosts Infection

    62 shares
    Share 25 Tweet 16
  • Breastmilk Balances E. coli and Beneficial Bacteria in Infant Gut Microbiomes

    58 shares
    Share 23 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Carboplatin ± Nivolumab in Metastatic TNBC Trial

New Numeracy Screener Developed for Preschoolers

Genetic Dosage Influences Parkinson’s Cognitive Decline

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 82 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.